Sulaiman A, Rakita R M, Arduino R C, Patterson J E, Steckelberg J M, Singh K V, Murray B E
Department of Internal Medicine, University of Texas Medical School, Houston 77030, USA.
Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):826-9. doi: 10.1007/BF01701529.
To assess the usefulness of Western blot in the diagnosis of enterococcal infections, a pilot study was conducted with a newly developed Western blot using sera from patients with confirmed enterococcal infections. Sera from 17 of 19 patients with enterococcal endocarditis reacted strongly to enterococcal antigens on the Western blot, and most produced specific bands at molecular weights 98 kDa and 54 kDa. Sera from patients with bacteremic cholangitis and pyelonephritis reacted frequently as well, but the pattern of bands was different from that observed with endocarditis. Eighty-five percent of 26 sera tested from patients with bacteremia and associated deep-seated infections (endocarditis, cholangitis, and pyelonephritis) were positive on Western blot, compared to 30% of sera from bacteremic patients with no clinically determined deep focus of infection (p < 0.001).
为评估蛋白质印迹法在肠球菌感染诊断中的实用性,开展了一项初步研究,使用新开发的蛋白质印迹法检测确诊为肠球菌感染患者的血清。19例肠球菌性心内膜炎患者中有17例的血清在蛋白质印迹法中与肠球菌抗原发生强烈反应,且大多数在分子量98 kDa和54 kDa处产生特异性条带。菌血症性胆管炎和肾盂肾炎患者的血清也经常出现反应,但条带模式与心内膜炎患者不同。在26例菌血症及相关深部感染(心内膜炎、胆管炎和肾盂肾炎)患者检测的血清中,85%在蛋白质印迹法中呈阳性,相比之下,无临床确定深部感染灶的菌血症患者血清阳性率为30%(p<0.001)。